| Alkaline phosphatase-based treatments of celiac disease |
2022-5-24 |
2022-12-01 |
|
| Microbiome protection from oral antibiotics |
2022-4-28 |
2022-7-20 |
|
| Alkaline phosphatase agents for treatment of neurodevelopmental disorders |
2022-4-21 |
2022-8-04 |
|
| Safe and effective beta-lactamase dosing for microbiome protection |
2022-1-10 |
2022-4-28 |
|
| Beta-lactamases with improved properties for therapy |
2021-12-08 |
2022-3-31 |
|
| Modified beta-lactamases and methods and uses related thereto |
2021-11-23 |
2022-3-24 |
|
| Carbapenemases for use with antibiotics for the protection of the intestinal … |
2021-8-19 |
2022-1-06 |
|
| E. coli-based production of beta-lactamase |
2021-5-07 |
2021-10-28 |
|
| Alkaline phosphatase formulations |
2021-3-29 |
2021-7-22 |
|
| Beta-lactamase formulations and uses thereof |
2020-9-28 |
2021-1-14 |
|
| Method and compositions for inhibiting or preventing adverse effects of oral … |
2020-8-20 |
2020-12-10 |
|
| Intestinal alkaline phosphatase-based treatments of metabolic disorders |
2020-7-16 |
2021-1-21 |
|
| Anti-methanogenic lovastatin analogs or derivatives and uses thereof |
2020-6-29 |
2021-1-21 |
|
| Alkaline phosphatase formulations and uses thereof |
2020-6-03 |
2020-12-10 |
|
| Alkaline phosphate-based oncology treatments |
2020-5-05 |
2022-6-30 |
|
| Beta-lactamase compositions for treatment of graft versus host disease |
2020-5-05 |
2022-3-16 |
|
| Anti-methanogenic compositions and uses thereof |
2020-4-27 |
2022-5-31 |
2022-5-31 |
| Methods of making alkaline phosphatase agents |
2019-6-17 |
2021-6-24 |
|
| Intestinal alkaline phosphatase formulations |
2019-3-20 |
2019-9-26 |
|
| Alkaline phosphatase agents for treatment of radiation disorders |
2019-3-20 |
2021-12-22 |
|
| Humanized pertussis antibodies and used thereof |
2018-6-25 |
2020-1-07 |
2020-1-07 |
| Beta-lactamase formulations |
2018-3-20 |
2020-4-09 |
|
| Methods and compositions for attenuating antibiotic resistance |
2017-10-31 |
2018-5-11 |
|
| Stabilized pertussis antibodies with extended half-life |
2017-8-15 |
2018-2-22 |
|
| Microbiome protection from oral antibiotics |
2017-6-28 |
2022-12-06 |
2022-12-06 |
| Clinically efficacious anti-methanogenic compositions and uses |
2017-6-21 |
2020-12-17 |
|
| Anti-methanogenic compositions |
2017-5-12 |
2017-11-23 |
|
| Methods and compositions for inhibiting clostridium difficile |
2015-11-04 |
2016-5-12 |
|
| Modified beta-lactamases and methods and uses related thereto |
2014-2-28 |
2015-4-30 |
2015-4-30 |
| Gastric retentive oral high dose zinc preparation |
2010-11-01 |
2013-3-14 |
|
| Oral zinc medicants useful for safely lowering free copper absorption and free … |
2008-3-12 |
2010-10-07 |
|
| Modified beta-lactamase and method for its preparation |
2007-6-19 |
2013-12-05 |
2013-12-05 |
| Non-sporulating Bacillus subtilis having parts of the gene encoding sigma G … |
2002-11-05 |
2008-1-15 |
2008-1-15 |
| Traitements à base de phosphatase alcaline de la maladie cœliaque |
2022-5-24 |
2022-12-01 |
|